Granite Bay Wealth Management LLC Acquires Shares of 2,184 HCA Healthcare, Inc. (NYSE:HCA)

Granite Bay Wealth Management LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, HoldingsChannel reports. The fund acquired 2,184 shares of the company’s stock, valued at approximately $733,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Bangor Savings Bank grew its holdings in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC grew its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the period. Finally, LifeSteps Financial Inc. acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $33,000. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HCA. Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Deutsche Bank Aktiengesellschaft upped their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Oppenheimer upped their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Stock Down 0.2 %

Shares of HCA stock opened at $405.45 on Wednesday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The firm’s 50-day moving average is $381.85 and its 200-day moving average is $344.10. The stock has a market cap of $106.19 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the business posted $4.29 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date was Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 over the last three months. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.